Search

Search Constraints

You searched for: Author/Creator Paget-Bailly, Sophie

Search Results

2. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

3. 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial. Issue 10191 (29th June 2019)

4. Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty. Issue 1 (December 2016)

5. Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty. Issue 1 (December 2016)

6. Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty. Issue 1 (December 2016)

7. Erratum to: Development and validation of the FRAGIRE tool for assessment an older person's risk for frailty. Issue 1 (December 2016)

8. Feasibility of a prehabilitation programme dedicated to older patients with cancer before complex medical–surgical procedures: the PROADAPT pilot study protocol. Issue 4 (2nd April 2021)

9. Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumab. (October 2018)